EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $1.39 | N/A |
Market Cap | $59.42M | N/A |
Shares Outstanding | 42.70M | 0.46% |
Employees | 0 | N/A |
Shareholder Equity | 14.58M | 28.05% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 2.36 | N/A |
P/B Ratio | 4.07 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.1690 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $25.21M | N/A |
Earnings | $2.46M | N/A |
Gross Margin | 0.7681 | N/A |
Operating Margin | 0.1243 | N/A |
Net income margin | 0.0977 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $11.97M | N/A |
Total Debt | $324.84K | N/A |
Cash on Hand | $9.39M | N/A |
Debt to Equity | 0.1424 | -17.01% |
Cash to Debt | $28.90 | N/A |
Current Ratio | $5.79 | 16.82% |